Evidence map›Paper›PMID 27273514›Full record

ArticleNature structural & molecular biology2016

The transcription factor ERG recruits CCR4-NOT to control mRNA decay and mitotic progression.

Xavier Rambout, Cécile Detiffe, Jonathan Bruyr, Emeline Mariavelle, Majid Cherkaoui, Sylvain Brohée, Pauline Demoitié, Marielle Lebrun, Romuald Soin, Bart Lesage and 12 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature structural & molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The RBPMSiScience · 2023
    Article
  6. Article
  7. Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Ewing sarcoma from molecular biology to the clinic.Frontiers in cell and developmental biology · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. hnRNPA2B1 inhibits the exosomal export of miR-503 in endothelial cells.Cellular and molecular life sciences : CMLS · 2020
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 3 countries.

Xavier RamboutInterdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège (ULg), Liège, Belgium.ORCID 0000-0002-5147-2863
Cécile DetiffeInterdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège (ULg), Liège, Belgium.
Jonathan BruyrInterdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège (ULg), Liège, Belgium.
Emeline MariavelleInterdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège (ULg), Liège, Belgium.
Majid CherkaouiInterdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège (ULg), Liège, Belgium.
Sylvain BrohéeBiGRe, Université Libre de Bruxelles (ULB), Bruxelles, Belgium.
Pauline DemoitiéInterdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège (ULg), Liège, Belgium.
Marielle LebrunInterdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège (ULg), Liège, Belgium.
Romuald SoinFaculté des Sciences, ULB, Gosselies, Belgium.
Bart LesageDepartment of Cellular and Molecular Medicine, University of Leuven (KUL), Leuven, Belgium.
Katia GuedriInterdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège (ULg), Liège, Belgium.
Monique BeullensDepartment of Cellular and Molecular Medicine, University of Leuven (KUL), Leuven, Belgium.
Mathieu BollenDepartment of Cellular and Molecular Medicine, University of Leuven (KUL), Leuven, Belgium.
Thalia A FaraziHoward Hughes Medical Institute, Rockefeller University, New York, New York, USA.
Richard KettmannInterdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège (ULg), Liège, Belgium.
Ingrid StrumanInterdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège (ULg), Liège, Belgium.
David E HillCenter for Cancer Systems Biology (CCSB), Department of Cancer Biology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA.
Marc VidalCenter for Cancer Systems Biology (CCSB), Department of Cancer Biology, Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, USA.
Véronique KruysFaculté des Sciences, ULB, Gosselies, Belgium.
Nicolas SimonisBiGRe, Université Libre de Bruxelles (ULB), Bruxelles, Belgium.
Jean-Claude TwizereInterdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège (ULg), Liège, Belgium.
Franck DequiedtInterdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège (ULg), Liège, Belgium.
University of Liège · BEKU Leuven · BEHarvard University · USUniversité Libre de Bruxelles · BEHoward Hughes Medical Institute · US

Funding

The C. elegans Interactome ProjectR01HG001715 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI HILL, DAVID E., ROTH, FREDERICK P · 1998 to 2010
$16.5M
NHGRI NIH HHS R01 HG001715
6 · The paper itself

Abstract

Control of mRNA levels, a fundamental aspect in the regulation of gene expression, is achieved through a balance between mRNA synthesis and decay. E26-related gene (Erg) proteins are canonical transcription factors whose previously described functions are confined to the control of mRNA synthesis. Here, we report that ERG also regulates gene expression by affecting mRNA stability and identify the molecular mechanisms underlying this function in human cells. ERG is recruited to mRNAs via interaction with the RNA-binding protein RBPMS, and it promotes mRNA decay by binding CNOT2, a component of the CCR4-NOT deadenylation complex. Transcriptome-wide mRNA stability analysis revealed that ERG controls the degradation of a subset of mRNAs highly connected to Aurora signaling, whose decay during S phase is necessary for mitotic progression. Our data indicate that control of gene expression by mammalian transcription factors may follow a more complex scheme than previously anticipated, integrating mRNA synthesis and degradation.

Indexed as

MitosisRNA Processing, Post-TranscriptionalAurora KinasesCell Line, TumorFibroblastsHEK293 CellsHeLa CellsHumansOsteoblastsProto-Oncogene Protein c-fli-1Repressor ProteinsRNA-Binding ProteinsRNA, MessengerRNA, Small InterferingRNA StabilitySignal TransductionAurora KinasesCNOT2 protein, humanERG protein, humanFLI1 protein, humanProto-Oncogene Protein c-fli-1RBPMS protein, humanRepressor ProteinsRNA-Binding ProteinsRNA, MessengerRNA, Small InterferingTranscriptional Regulator ERG

Identifiers

PMID27273514
OpenAlexW2427723510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.